$79.74
0.49[0.62%]
At close: Apr 26
$79.74
0[0.00%]
After Hours: 4:06PM EDT
Medtronic: Insider buying and selling updated today.
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
---|---|---|---|---|---|---|---|---|---|---|
Apr 09, 2024 | Michael Marinaro | EVP & PRESIDENT, SURGICAL OU | -854 | $83.14 | -$71.00K | SELL | -2.97% | 27.925K | Apr 08 | View |
Feb 23, 2024 | Sean Salmon | EVP & PRESIDENT CARDIOVASCULAR | 0 | $77.10 | -$492.93K | SELL-OPTIONS | 0.00% | 48.289K | Feb 21 | View |
Dec 20, 2023 | Brett Wall | EVP & PRES NEUROSCIENCE | -4.997K | $82.17 | -$410.60K | SELL | -14.74% | 28.91K | Dec 19 | View |
Aug 25, 2023 | Gregory Smith | EVP GLOBAL OPS & SUPPLY CHAIN | -10K | $83.84 | -$838.40K | SELL | -17.63% | 46.723K | Aug 23 | View |
Aug 16, 2023 | Brett Wall | EVP & PRES NEUROSCIENCE | -1K | $83.38 | -$83.38K | SELL | -2.89% | 33.573K | Aug 14 | View |
Aug 07, 2023 | Michael Marinaro | EVP & PRESIDENT, SURGICAL OU | -979 | $84.30 | -$225.50K | SELL | -3.27% | 28.93K | Aug 03 - Aug 04 | View |
Jul 18, 2023 | Brett Wall | EVP & PRES NEUROSCIENCE | -2K | $87.97 | -$175.94K | SELL | -7.71% | 23.948K | Jul 14 | View |
Jul 12, 2023 | ROB HOEDT TEN | EVP AND PRES. GLOBAL REGIONS | 0 | $70.95 | -$172.39K | SELL-OPTIONS | 0.00% | 43.802K | Jul 10 | View |
Dec 16, 2022 | Sean Salmon | EVP & PRESIDENT CARDIOVASCULAR | 0 | $67.91 | -$418.71K | SELL-OPTIONS | 0.00% | 36.088K | Dec 13 | View |
Oct 17, 2022 | ROB HOEDT TEN | EVP AND PRES. GLOBAL REGIONS | 0 | $61.57 | -$96.01K | SELL-OPTIONS | 0.00% | 43.483K | Oct 14 | View |
Mar 21, 2022 | KAREN PARKHILL | EVP & CHIEF FINANCIAL OFFICER | -682 | $110.00 | -$75.02K | SELL | -0.80% | 84.805K | Mar 18 | View |
Mar 14, 2022 | Carol Surface | SVP, CHIEF HR OFFICER | -6K | $105.30 | -$631.80K | SELL | -17.10% | 29.078K | Mar 11 | View |
Dec 27, 2021 | JOHN ROBERT WHITE | EVP & PRES. MEDICAL SURGICAL | -7.218K | $102.04 | -$736.52K | SELL | -14.99% | 40.93K | Dec 23 | View |
Dec 17, 2021 | RICHARD ANDERSON | DIRECTOR | 5.01K | $103.26 | $517.33K | BUY | 4.63% | 113.174K | Dec 16 | View |
Dec 07, 2021 | KAREN PARKHILL | EVP & CHIEF FINANCIAL OFFICER | -682 | $110.00 | -$75.02K | SELL | -1.84% | 36.289K | Dec 06 | View |
Oct 01, 2021 | Bradley Lerman | SVP GENERAL COUNSEL & CORP SEC | 0 | $102.29 | -$2.39M | SELL-OPTIONS | 0.00% | 48.763K | Sep 30 | View |
Sep 01, 2021 | Bradley Lerman | SVP GENERAL COUNSEL & CORP SEC | 0 | $104.50 | -$3.01M | SELL-OPTIONS | 0.00% | 48.763K | Aug 31 | View |
Aug 26, 2021 | Sean Salmon | EVP & PRES DIABETES/CARDIOVASC | 0 | $86.40 | -$2.71M | SELL-OPTIONS | 0.00% | 33.329K | Aug 25 | View |
Aug 26, 2021 | Geoffrey Martha | CEO | 0 | $97.24 | -$820.65K | SELL-OPTIONS | 0.00% | 95.836K | Aug 25 | View |
Browse insider trades on all stocks.